Yatharth Hospital and Trauma Care Services Limited (YATHARTH) AI Stock Analysis

3 Followers

Yatharth Hospital and Trauma Care Services Limited

(NSE:YATHARTH)

Select Model

Rating:62Neutral

Price Target:INR 1,042.00▲(1.42% Upside)

Action:reiterated

Date:09/18/26

The score is driven primarily by solid operating performance and improved leverage, but is capped by persistently negative free cash flow and a high P/E valuation. Technicals are supportive, with a strong uptrend and positive momentum.

Positive Factors

Strong Revenue GrowthStrong revenue expansion indicates increasing patient volumes, service utilization, or hospital capacity, supporting scale benefits across the network. Continued growth can broaden the company’s clinical footprint and create a durable base for future earnings, provided profitability remains healthy as operations expand.

Negative Factors

Negative Free Cash FlowPersistent negative free cash flow means reported profit is not currently translating into surplus cash after investment and working-capital needs. This can constrain internally funded expansion, increase reliance on financing, and reduce flexibility if the company must sustain elevated spending to grow.

Yatharth Hospital and Trauma Care Services Limited (YATHARTH) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 99.39B
Dividend Yield: 0.05%
Average Volume (3M): 34.09K
Price to Earnings (P/E): 52.0
Beta (1Y): 1.30
Revenue Growth: 50.40%
EPS Growth: 24.94%
Country: India
Employees: 7,440
Sector: General
Sector Strength: 55
Industry: Medical - Care Facilities

Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model

Company Description

Established in 2008 and headquartered in Noida, India, Yatharth Hospital & Trauma Care Services Limited operates and manages super-specialty medical facilities across Delhi and Madhya Pradesh. These hospitals offer an extensive range of healthcare se...

Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview

Summary

Strong revenue growth and healthy profitability support the score, and leverage has improved meaningfully versus earlier years. The key drag is weak cash conversion: free cash flow is negative in both FY2025 and FY2026 and cash flows have been volatile, which reduces near-term flexibility despite reported earnings growth.

Income Statement

76Positive

Balance Sheet

71Positive

Cash Flow

42Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	13.34B	12.07B	8.80B	6.71B	5.20B	4.01B
Gross Profit	7.90B	6.50B	5.39B	5.37B	4.27B	3.20B
EBITDA	3.35B	2.92B	2.36B	1.96B	1.37B	1.13B
Net Income	1.81B	1.75B	1.31B	1.14B	657.68M	441.62M
Balance Sheet
Total Assets	0	22.82B	17.31B	10.19B	4.86B	4.26B
Cash, Cash Equivalents and Short-Term Investments	2.63B	2.98B	5.15B	2.39B	382.36M	120.31M
Total Debt	0	2.64B	115.86M	846.47M	2.67B	2.64B
Total Liabilities	-18.07B	4.74B	940.45M	1.45B	3.03B	3.09B
Stockholders Equity	18.07B	17.81B	16.05B	8.74B	1.83B	1.17B
Cash Flow
Free Cash Flow	-1.49B	-956.83M	-1.61B	-964.43M	439.70M	468.01M
Operating Cash Flow	485.14M	2.21B	1.50B	-30.78M	637.84M	599.35M
Investing Cash Flow	-2.51B	-6.17B	-4.20B	-2.26B	-203.10M	-521.75M
Financing Cash Flow	142.57M	2.56B	5.19B	3.04B	-177.48M	-11.24M

Yatharth Hospital and Trauma Care Services Limited Technical Analysis

Technical Analysis SentimentPositive

Last Price1027.45

Price Trends

50DMA999.06Negative

100DMA921.90Positive

200DMA817.86Positive

Market Momentum

MACD-19.13Positive

RSI51.70Neutral

STOCH57.11Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Positive. The current price of 1027.45 is above the 20-day moving average (MA) of 971.10, above the 50-day MA of 999.06, and above the 200-day MA of 817.86, indicating a neutral trend. The MACD of -19.13 indicates Positive momentum. The RSI at 51.70 is Neutral, neither overbought nor oversold. The STOCH value of 57.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:YATHARTH.

Yatharth Hospital and Trauma Care Services Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:YATHARTH against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:ARTEMISMED	68Neutral	INR 45.16B	39.30	―	0.15%	14.96%	20.76%
IN:NH	67Neutral	INR 382.05B	45.75	―	0.23%	71.40%	1.76%
IN:MAXHEALTH	63Neutral	INR 870.14B	65.38	―	0.22%	15.17%	1.63%
IN:YATHARTH	62Neutral	INR 94.74B	51.99	―	0.05%	50.40%	24.94%
IN:APOLLOHOSP	62Neutral	INR 1.21T	59.17	―	0.23%	17.20%	32.79%
IN:FORTIS	60Neutral	INR 592.26B	56.96	―	0.13%	17.50%	20.65%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

IN:YATHARTH and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:YATHARTH	Yatharth Hospital and Trauma Care Services Limited	1027.45	232.97	29.32%
IN:APOLLOHOSP	Apollo Hospitals Enterprise Limited	8577.00	812.17	10.46%
IN:ARTEMISMED	Artemis Medicare Services Ltd.	300.60	57.76	23.78%
IN:FORTIS	Fortis Healthcare Ltd.	790.90	-218.43	-21.64%
IN:MAXHEALTH	Max Healthcare Institute Ltd	926.00	-198.60	-17.66%
IN:NH	Narayana Hrudayalaya Ltd.	1929.30	112.98	6.22%

Yatharth Hospital and Trauma Care Services Limited Corporate Events

Yatharth Hospital boosts authorised capital and secures major minority investment

Sep 17, 2026

Yatharth Hospital & Trauma Care Services Limited’s board has approved an increase in authorised share capital from INR 115 crore to INR 150 crore, subject to shareholder and regulatory approvals, requiring an amendment to its Memorandum of...

Yatharth Hospital Challenges Large Tax Demands After Final Assessments

Sep 14, 2026

Yatharth Hospital and its subsidiaries AKS Medical & Research Centre and Ramraja Multispeciality Hospital have received final income tax assessment orders from the Delhi tax authorities, raising aggregate demands of over Rs. 43 crores in tax and...

Yatharth Hospital Files FY 2025-26 Business Responsibility and Sustainability Report

Sep 3, 2026

Yatharth Hospital and Trauma Care Services Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 to the National Stock Exchange of India and BSE Limited in compliance with SEBI disclosure regulatio...

Yatharth Hospital to Join Nuvama India 2026 Investor Conference via Virtual Meet

Aug 8, 2026

Yatharth Hospital and Trauma Care Services has announced that its management will participate in the Nuvama India Conference 2026 (Singapore Edition) on August 12, 2026, via a virtual investor meeting. The company emphasized that no unpublished price...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 18, 2026

Yatharth Hospital and Trauma Care Services Limited AI Stock Analysis